Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LAKE FOREST, Ill., May 1, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, today reported results for the first quarter ended March 31, 2013. Adjusted* net sales for the quarter were $988 million and adjusted* diluted earnings per share were $0.52. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.)
Help employers find you! Check out all the jobs and post your resume.
